Medicamen Organics Limited — Important, 30-12-2024: Updates

Medicamen Organics Limited has incorporated a subsidiary, Grande Etoile Pharmaceuticals Limited (GEPL), with an authorized share capital of ₹1 crore and paid-up capital of ₹50 lakhs. Medicamen holds 50.92% of GEPL, while the remaining shares are held by other stakeholders. GEPL aims to operate within the Pharmaceuticals, Healthcare, and Cosmetics industries, focusing on manufacturing, processing, and retailing pharmaceutical products and cosmetics. This strategic move is expected to enhance Medicamen's presence and diversify its product offerings in the healthcare sector. The incorporation positions the company to tap into new markets and expand its distribution network. Investors should observe this development as it may signify potential growth opportunities through diversified revenue streams.